Sort   by:  
 Page size 
UnknownMachine learning approach to identify phenotypes in patients with ischaemic heart failure with reduced ejection fraction.
Not available
S-EPMC12803694 | biostudies-literature
UnknownInflammation and remodeling pathways and risk of cardiovascular events in patients with ischemic heart failure and reduced ejection fraction.
Not available
S-EPMC9123183 | biostudies-literature
UnknownHeart Failure Clinical Trials in East and Southeast Asia: Understanding the Importance and Defining the Next Steps.
Not available
S-EPMC4893168 | biostudies-literature
UnknownNear-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trial.
Not available
S-EPMC12208775 | biostudies-literature
UnknownThe influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure.
Not available
S-EPMC7042190 | biostudies-literature
UnknownImproved cardiac and venous pressures during hospital stay in patients with acute heart failure: an echocardiography and biomarkers study.
Not available
S-EPMC7261539 | biostudies-literature
UnknownCardiovascular effects of rivaroxaban in heart failure patients with sinus rhythm and coronary disease with and without diabetes: a retrospective international cohort study from COMMANDER-HF.
Not available
S-EPMC10423780 | biostudies-literature
UnknownPathophysiological pathways in patients with heart failure and atrial fibrillation.
Not available
S-EPMC9400416 | biostudies-literature
UnknownRelationship between NT-proBNP, echocardiographic abnormalities and functional status in patients with subclinical siabetic cardiomyopathy.
Not available
S-EPMC11297788 | biostudies-literature
UnknownMachine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction.
Not available
S-EPMC8360080 | biostudies-literature
Sort   by:  
 Page size